![](https://d3ilqtpdwi981i.cloudfront.net/FkmYiEyxDjsssU3lIFoYu_AJVqw=/0x47:371x527/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/f1/cd/08/f1cd087f-92ee-4fdb-bc38-5d9483e1bf14/BHSF%20Pineapple%20Logo%20%28Imported%20Works%29.png)
Presentation
Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge
All Publications
Publication Date
4-1-2019
Presented At:
QCOR 2019 Scientific Sessions
Content Type
application/pdf
Disciplines
Citation Information
Amy Starosciak and Felipe De Los Rios La Rosa. "Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge" (2019) Available at: http://works.bepress.com/amy_starosciak/31/